Jeffrey L Emery

Title: **Innovative Contributions of Jeffrey L. Emery**

Introduction

Jeffrey L. Emery is a distinguished inventor based in San Mateo, California. With a focus on advancing medical technology, he has made significant contributions to the field with his inventive ingenuity. His work primarily revolves around catheter systems that enhance the efficacy of medical procedures involving blood vessels.

Latest Patents

Jeffrey holds one notable patent titled "Catheter system for vascular re-entry from a sub-intimal space." This innovative catheter system encompasses methods for accessing a blood vessel's true lumen from a sub-intimal plane, particularly advantageous for cases involving chronic total occlusions (CTOs). The design includes visualization components that assist in orienting the true lumen concerning the sub-intimal plane at a specified entry site. Additionally, this system features mechanisms for securely anchoring tissue at the entry point, thus minimizing catheter movement within the sub-intimal space. Re-entry devices integrated into the system aim to establish and sustain a pathway back into the vessel's true lumen, significantly improving procedural outcomes.

Career Highlights

Currently, Jeffrey L. Emery is associated with Lumend, Inc., where he continues to innovate and develop cutting-edge medical solutions. His patent demonstrates his commitment to improving vascular interventions and highlights his role in advancing catheter technologies.

Collaborations

Throughout his career, Jeffrey has collaborated with notable colleagues such as Kurt Sparks and Brent Seybold. These professional partnerships have fostered innovative discussions and idea exchanges, further enhancing his contributions to the field of medical technology.

Conclusion

Jeffrey L. Emery exemplifies the spirit of innovation within the medical sector. His patent for a catheter system not only showcases his technical prowess but also underscores the importance of collaboration in driving advancements in healthcare. As he continues to work at Lumend, Inc., the medical community can anticipate more groundbreaking innovations that can transform patient care practices.